Humacyte
HUMA
HUMA
75 hedge funds and large institutions have $25.1M invested in Humacyte in 2022 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 33 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
6% less call options, than puts
Call options by funds: $32K | Put options by funds: $34K
35% less capital invested
Capital invested by funds: $38.7M → $25.1M (-$13.6M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
75
Holding in Top 10
1
Calls
$32K
Puts
$34K
Top Buyers
| 1 | +$3.8M | |
| 2 | +$579K | |
| 3 | +$418K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$408K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$367K |
Top Sellers
| 1 | -$4.56M | |
| 2 | -$1.94M | |
| 3 | -$1.38M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$628K |
| 5 |
Renaissance Technologies
New York
|
-$387K |